Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline.
Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline.
复制标题
骨质疏松症与阿尔茨海默氏症、轻度认知障碍和认知功能下降有关。
DOI:
10.1111/jgs.17206
复制
发表时间:
2021-07
影响因子:
6.3
通讯作者:
Buchman AS
中科院分区:
文献类型:
--
作者:
Beeri MS;Leugrans SE;Delbono O;Bennett DA;Buchman AS
We examined whether sarcopenia is associated with the occurrence of late-life cognitive impairment. Nondemented older adults (N = 1175) underwent annual testing with 17 cognitive tests summarized as a global cognitive score. A composite sarcopenia score was constructed based on muscle mass measured with bioelectrical impedance and muscle function based on grip strength. Cox proportional hazard models were employed to examine associations of sarcopenia with incident Alzheimer's dementia (AD) and incident mild cognitive impairment (MCI). Linear mixed-effect models determined the association of sarcopenia with cognitive decline. All models controlled for age, sex, education, race, and height squared. Average follow-up was 5.6 years. More severe sarcopenia at baseline was associated with a higher risk of incident AD (hazard ratio [HR], 1.50 [95% confidence interval 1.20–1.86]; p < 0.001) and of MCI (1.21 [1.01–1.45]; 0.04) and a faster rate of cognitive decline (estimate =0.013; p = 0.01). Analyses of the individual components of sarcopenia showed that muscle function was associated with incident AD, incident MCI, and cognitive decline with and without a term for lean muscle mass in the model. In contrast, lean muscle mass was not associated with incident cognitive impairment or cognitive decline when a term for muscle function was included in the model. Poor muscle function, but not reduced lean muscle mass, drives the association of sarcopenia with late-life cognitive impairment. Further work is needed to identify features of muscle structure, which may increase the specificity of sarcopenia for identifying older adults at risk for late-life cognitive impairment.
登录
查看更多内容
影响因子:
6.3
作者:
Cawthon PM;Manini T;Patel SM;Newman A;Travison T;Kiel DP;Santanasto AJ;Ensrud KE;Xue QL;Shardell M;Duchowny K;Erlandson KM;Pencina KM;Fielding RA;Magaziner J;Kwok T;Karlsson M;Ohlsson C;Mellström D;Hirani V;Ribom E;Correa-de-Araujo R;Bhasin S
通讯作者:
Bhasin S
DOI:
10.3233/jad-179939
发表时间:
2018
期刊:
Journal of Alzheimer's disease : JAD
影响因子:
--
作者:
Bennett DA;Buchman AS;Boyle PA;Barnes LL;Wilson RS;Schneider JA
通讯作者:
Schneider JA
影响因子:
3.3
作者:
Cederholm, Tommy E.;Bauer, Juergen M.;Rolland, Yves
通讯作者:
Rolland, Yves
影响因子:
16.2
作者:
Sam, Susan;Haffner, Steven;Mazzone, Theodore
通讯作者:
Mazzone, Theodore
影响因子:
3.3
作者:
Janssen, I;Heymsfield, SB;Ross, R
通讯作者:
Ross, R